ASPEN PHARMACARE HOLDINGS LTD

ASPEN PHARMACARE HOLDINGS LTD Organogram

Aspen Pharmacare Holdings Ltd, operating through its subsidiaries, manufactures, markets, imports, and distributes branded and generic pharmaceutical products, consumer healthcare, as well as treatments for acute and chronic conditions, covering both hospital and consumer markets through its key business segments.\r\n\r\nAspen presently supplies medicines to 115 countries through 65 established offices in 50 countries and territories. The group operates 23 manufacturing facilities (7 active manufacturing and 16 finished dose form facilities) on 15 sites across 6 continents. \r\n\r\nOperations are undertaken through the following segments:\r\n• Commercial Pharmaceuticals:\r\n- Regional Brands - a widely diverse segment comprising predominantly leading domestic brands in the sub-Saharan Africa, Australasia, and Latin American territories\r\n• Sterile Focus Brands - focuses on sterile products comprising Anesthetics Brands and Thrombosis Brands that are distributed to hospitals for use in acute settings\r\n- Anesthetics - includes a range of general anesthetics, muscle relaxants as well as several local anesthetics including topical agents\r\n- Thrombosis - comprises a range of specialist injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives\r\n• Manufacturing:\r\n- Contracts and supplies chemical and bio-chemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties\r\n\r\nManufacturing sites as follows:\r\n4 - South Africa (Johannesburg; East London; Cape Town; Gqeberha)\r\n2 - Mexico (leased)\r\n3 - The Netherlands\r\n2 - France\r\n1 - Australia\r\n1 - Kenya\r\n1 - Tanzania\r\n1 - Brazil\r\n1 - Germany\r\n1 - Ireland\r\n1 - USA\r\n1 - Ghana\r\n1 - India